Have a personal or library account? Click to login
From ancient roots to modern routes: a systematic review of ginger’s anti-motion sickness efficacy in randomized clinical trials and animal studies Cover

From ancient roots to modern routes: a systematic review of ginger’s anti-motion sickness efficacy in randomized clinical trials and animal studies

Open Access
|Mar 2026

Abstract

Motion sickness is a neurosensory dysfunction characterised by nausea, vomiting, dizziness, and general discomfort. Although there are conventional medications for this condition, interest in herbal alternatives like ginger (Zingiber officinale) is growing due to its broad biological activities and safety profile. Usually, females are more prone to motion sickness. Ginger contains phenolic chemicals that have anti-inflammatory, anti-microbial, anti-cancer, neuroprotective, anti-diabetic, cardiovascular, anti-obesity, anti-emetic, and protective actions against respiratory illnesses. These biological activities have led to its usage in traditional medicine to treat symptoms such as motion sickness, morning sickness, nausea, vomiting, indigestion, nausea and vomiting induced by chemotherapy and pregnancy. This systematic review of randomised controlled trials (RCTs) and animal studies was conducted using PubMed, Web of Science, and DOAJ in accordance with PRISMA guidelines. Four RCTs (involving 469 participants) and only one animal study met the inclusion criteria, and ginger was administered in doses ranging from 500 to 2,000 mg. One RCT study, which used low-dose ginger, revealed ginger to be less beneficial than a multivitamin-based treatment, whereas three trials reported a significant decrease in nausea and vomiting compared to a placebo. There were no significant side effects noted. In conclusion, these investigations have shown that ginger is effective and tolerable in treating motion sickness. Although there is a lot of evidence supporting ginger’s safety, effectiveness, and reduction of motion sickness, additional research is needed to ensure its efficacy.

Language: English
Page range: 1 - 16
Accepted on: Feb 24, 2026
|
Published on: Mar 28, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 ArunSundar Mohana Sundaram, Murali Krishna Kandukuri, Keerthana Bharathi, Richel Pooja Maram Rock, Bharathi Sridhar, Naveen Akshinthala Purushotham, Vijaya Kumar Voleti, Meng-Yao Li, Maima Matin, Atanas G. Atanasov, published by Institute of Genetics and Animal Biotechnology of the Polish Academy of Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.